These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23688150)
21. Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II. Battaglia G; Rassoulpour A; Wu HQ; Hodgkins PS; Kiss C; Nicoletti F; Schwarcz R J Neurochem; 2000 Nov; 75(5):2051-60. PubMed ID: 11032894 [TBL] [Abstract][Full Text] [Related]
22. mGluR5 antagonists: discovery, characterization and drug development. Gasparini F; Bilbe G; Gomez-Mancilla B; Spooren W Curr Opin Drug Discov Devel; 2008 Sep; 11(5):655-65. PubMed ID: 18729017 [TBL] [Abstract][Full Text] [Related]
23. Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1. Suzuki Y; Moriyoshi E; Tsuchiya D; Jingami H J Biol Chem; 2004 Aug; 279(34):35526-34. PubMed ID: 15199056 [TBL] [Abstract][Full Text] [Related]
24. Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors. Thibado JK; Tano JY; Lee J; Salas-Estrada L; Provasi D; Strauss A; Marcelo Lamim Ribeiro J; Xiang G; Broichhagen J; Filizola M; Lohse MJ; Levitz J Elife; 2021 Apr; 10():. PubMed ID: 33880992 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: new insights into the activation process. Bessis AS; Bertrand HO; Galvez T; De Colle C; Pin JP; Acher F Protein Sci; 2000 Nov; 9(11):2200-9. PubMed ID: 11152130 [TBL] [Abstract][Full Text] [Related]
26. Molecular dynamic simulation of mGluR5 amino terminal domain: essential dynamics analysis captures the agonist or antagonist behaviour of ligands. Casoni A; Clerici F; Contini A J Mol Graph Model; 2013 Apr; 41():72-8. PubMed ID: 23500630 [TBL] [Abstract][Full Text] [Related]
27. Conformational rearrangement during activation of a metabotropic glutamate receptor. Liauw BW; Afsari HS; Vafabakhsh R Nat Chem Biol; 2021 Mar; 17(3):291-297. PubMed ID: 33398167 [TBL] [Abstract][Full Text] [Related]
28. Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors. Llinas Del Torrent C; Pérez-Benito L; Tresadern G Molecules; 2019 Mar; 24(6):. PubMed ID: 30897742 [TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulations of the conformational changes of the glutamate receptor ligand-binding core in the presence of glutamate and kainate. Mendieta J; Ramírez G; Gago F Proteins; 2001 Sep; 44(4):460-9. PubMed ID: 11484223 [TBL] [Abstract][Full Text] [Related]
31. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site. Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635 [TBL] [Abstract][Full Text] [Related]
32. Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand. Dalton JAR; Pin JP; Giraldo J Sci Rep; 2017 Jul; 7(1):4944. PubMed ID: 28694498 [TBL] [Abstract][Full Text] [Related]
33. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands. Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663 [TBL] [Abstract][Full Text] [Related]
34. New allosteric modulators of metabotropic glutamate receptor 5 (mGluR5) found by ligand-based virtual screening. Renner S; Noeske T; Parsons CG; Schneider P; Weil T; Schneider G Chembiochem; 2005 Apr; 6(4):620-5. PubMed ID: 15744765 [No Abstract] [Full Text] [Related]
35. A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. Niswender CM; Johnson KA; Luo Q; Ayala JE; Kim C; Conn PJ; Weaver CD Mol Pharmacol; 2008 Apr; 73(4):1213-24. PubMed ID: 18171729 [TBL] [Abstract][Full Text] [Related]
36. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists. Johnson MP; Kelly G; Chamberlain M J Neuroendocrinol; 2001 Aug; 13(8):670-7. PubMed ID: 11489083 [TBL] [Abstract][Full Text] [Related]
37. Agonists and antagonists for group III metabotropic glutamate receptors 6, 7 and 8. Yang ZQ Curr Top Med Chem; 2005; 5(9):913-8. PubMed ID: 16178735 [TBL] [Abstract][Full Text] [Related]
38. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus. de Mendonça A; Ribeiro JA Br J Pharmacol; 1997 Aug; 121(8):1541-8. PubMed ID: 9283686 [TBL] [Abstract][Full Text] [Related]
39. Site selective activation of lateral hypothalamic mGluR1 and R5 receptors elicits feeding in rats. Charles JR; Hernandez E; Winter A; Yang CR; Stanley BG Physiol Behav; 2015 Feb; 139():261-6. PubMed ID: 25449406 [TBL] [Abstract][Full Text] [Related]
40. Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer. Xue L; Rovira X; Scholler P; Zhao H; Liu J; Pin JP; Rondard P Nat Chem Biol; 2015 Feb; 11(2):134-40. PubMed ID: 25503927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]